Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain
NCT ID: NCT06977100
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2025-08-11
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary aims of this study are to:
* Assess whether individuals with TMD and chronic overlapping pain are able to complete the 2-week gratitude journaling activity as planned (feasibility).
* Evaluate how acceptable participants find the gratitude journaling activity (acceptability).
The secondary aim of this study is to:
• Explore whether the gratitude journaling activity reduces pain and its impact on daily life, compared to a general wellness journaling activity.
Participants will:
* Attend two in-person visits to complete questionnaires and take part in tests that measure how sensitive they are to pressure and heat.
* Complete a 2-week journaling activity at home, writing in their journal on three days of their choice per week.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Resilience In Orofacial Pain and Nociception
NCT02164630
Brief Treatment for Temporomandibular Pain
NCT00067366
Effectiveness of Brief Mindfulness-Based Interventions for Painful Temporomandibular Disorders Among University Students
NCT06582134
Effectiveness of a Counseling Program for Temporomandibular Disorders (TMD) Treatment
NCT02380105
Cytokine and Growth Factor Changes and Correlation With Clinical Outcomes Following Acupuncture for TMD
NCT02324712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gratitude Intervention
Gratitude
Participants in this group will receive a gratitude journal where they will be asked to write down three things they are grateful for each day and reflect why they are grateful for these things. Journaling will take place from the comfort of their home on three days of their choice per week, for a total duration of two weeks.
General Wellness
General Wellness
Participants in this group will receive a general wellness journal where they will be asked to reflect on three things that happened, or they did during the day (daily activities). Journaling will take place from the comfort of their home on three days of their choice per week, for a total duration of two weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gratitude
Participants in this group will receive a gratitude journal where they will be asked to write down three things they are grateful for each day and reflect why they are grateful for these things. Journaling will take place from the comfort of their home on three days of their choice per week, for a total duration of two weeks.
General Wellness
Participants in this group will receive a general wellness journal where they will be asked to reflect on three things that happened, or they did during the day (daily activities). Journaling will take place from the comfort of their home on three days of their choice per week, for a total duration of two weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pain in the temporomandibular (TMD) region (jaw and/or temple area)
* duration of pain is at least 3 months
* average pain score ≥4 on a 0-10 numerical rating scale over the past week
* have at least one additional chronic overlapping pain condition (COPC) including fibromyalgia, irritable bowel syndrome, migraine-type headache, tension-type headache, low back pain, interstitial cystitis/painful bladder syndrome or chronic prostatitis, myalgic encephalomyelitis/chronic fatigue syndrome, vulvodynia, and painful endometriosis.
* able to read, understand, and write in English.
Exclusion Criteria
* neoplasm or injury/trauma to the TMD area
* cancer-related pain
* scheduled for any surgeries during the study time-frame
* current participation in another clinical trial or psychological treatment for any pain-related condition that would interfere with study outcomes
* pregnant or lactating
* severe motor impairments (e.g., muscular dystrophy)
* severe psychiatric conditions (e.g., uncontrolled mood disorders)
* severe neurological or cognitive impairments (e.g., uncontrolled Parkinson's disease)
* any other conditions that in the opinion of study investigators could make participation in the study unsafe
* use of opioids within 48 hours prior to laboratory visit
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Florida
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB202500344
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.